2015 News + Events
2013 News + Events

Firsthand Technology Value Fund Completes Purchase of IntraOp Medical

SAN JOSE, Calif., Oct 07, 2013 — Firsthand Technology Value Fund, Inc. SVVC, +0.00% (“Firsthand” or the “Fund”), a publicly-traded venture capital fund that invests in technology and cleantech companies, announced today that it has completed its purchase of a majority interest in IntraOp Medical Corporation (“IntraOp”). IntraOp has developed a revolutionary medical device called the Mobetron, … Continued

Read More
2012 News + Events

IORT Now Available at St. Lukes

Advancing on Cancer: Intraoperative radiation therapy now available at St. Luke’s – Cedar Rapids St. Luke’s now provides intraoperative radiation therapy (IORT) for early stage breast cancer patients through an international clinical trial. IORT combines surgery with an initial, concentrated dose of radiation precisely focused on the area where most breast cancers recur. This is … Continued

Read More

Reduce Breast Cancer Treatment from Six Weeks to One Day

A European cancer center of excellence, Ospedale Borgo Trento in Verona, Italy, recently published a study of 226 women with early-stage breast cancer that received a single dose of Intra-Operative Electron Radiation Therapy (IOERT) using the IntraOp Medical Corporation Mobetron®

Read More

The Best Radiation Therapy Solution Just Got Better

SUNNYVALE, Calif., July 18, 2012 /PRNewswire IntraOp Medical Corporation (OTC: IOPD.PK – News) installed the 10th of the next generation Mobetrons last week at Helios-Kliniken (helios-kliniken.de) in Berlin Germany.  The Mobetron is used for electron IORT (IOERT), which has demonstrated the best overall clinical results of any breast cancer treatment, resulting in 10 year recurrence rates as low as 1%.  Currently each Mobetron in Germany treats between 250-350 breast … Continued

Read More